CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...